{"id":35841,"date":"2025-10-06T10:02:48","date_gmt":"2025-10-06T08:02:48","guid":{"rendered":"https:\/\/ggba.swiss\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/"},"modified":"2025-10-06T10:09:33","modified_gmt":"2025-10-06T08:09:33","slug":"spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/","title":{"rendered":"Spineart l\u00e8ve CHF 25 millions pour acc\u00e9l\u00e9rer son expansion mondiale"},"content":{"rendered":"\n<p>Fond\u00e9e \u00e0 Gen\u00e8ve, <a href=\"https:\/\/www.spineart.com\/\">Spineart<\/a> s\u2019est impos\u00e9e comme l\u2019un des principaux innovateurs medtech suisses, alliant excellence du design et technologies avanc\u00e9es de navigation num\u00e9rique et robotique. L\u2019entreprise est notamment connue pour sa proth\u00e8se cervicale BAGUERA\u00ae C, une g\u00e9n\u00e9ration de disques intervert\u00e9braux con\u00e7ue pour pr\u00e9server la mobilit\u00e9 et r\u00e9duire les complications chez les patients atteints de troubles d\u00e9g\u00e9n\u00e9ratifs du rachis cervical. Apr\u00e8s avoir achev\u00e9 ses \u00e9tudes cliniques IDE (Investigational Device Exemption) aupr\u00e8s de la FDA, Spineart poursuit d\u00e9sormais les d\u00e9marches d\u2019homologation aux \u00c9tats-Unis.<\/p>\n\n\n\n<p>La strat\u00e9gie de croissance de Spineart repose sur un portefeuille d\u2019implants de haute pr\u00e9cision, de syst\u00e8mes de navigation et de technologies robotiques. La soci\u00e9t\u00e9 a r\u00e9cemment inaugur\u00e9 une nouvelle usine de production de 4\u2019000 m\u00b2 \u00e0 Reignier, en France, ainsi qu\u2019un centre de R&amp;D et de formation d\u00e9di\u00e9 aux technologies d\u2019assistance chirurgicale \u00e0 Dallas, au Texas, destin\u00e9 \u00e0 accompagner son r\u00e9seau croissant de chirurgiens et de partenaires de sant\u00e9.<\/p>\n\n\n\n<p>Avec plus de 360 collaborateurs dans le monde, Spineart pr\u00e9voit d\u2019atteindre un chiffre d\u2019affaires d\u2019environ EUR 140 millions en 2025, marquant ainsi cinq ann\u00e9es cons\u00e9cutives de croissance \u00e0 deux chiffres. Son expansion continue en Europe et aux \u00c9tats-Unis illustre son ambition de devenir un acteur mondial de r\u00e9f\u00e9rence dans l\u2019innovation en chirurgie rachidienne.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Fa\u00e7onner l\u2019avenir de la chirurgie du rachis<\/h4>\n\n\n\n<p>\u00ab Cet investissement repr\u00e9sente une \u00e9tape majeure dans notre parcours de croissance rentable, \u00bb a d\u00e9clar\u00e9 J\u00e9r\u00f4me Trividic, CEO de Spineart. \u00ab Gr\u00e2ce au soutien continu de Gimv et d\u2019EGSB, nous sommes id\u00e9alement positionn\u00e9s pour acc\u00e9l\u00e9rer notre d\u00e9veloppement mondial, proposer des technologies innovantes et diff\u00e9renci\u00e9es, et renforcer notre engagement envers l\u2019excellence chirurgicale et l\u2019am\u00e9lioration des r\u00e9sultats pour les patients. \u00bb<\/p>\n\n\n\n<p><a href=\"https:\/\/www.gimv.com\/\">Gimv<\/a> et <a href=\"https:\/\/www.egs-beteiligungen.ch\/\">EGSB<\/a> ont r\u00e9affirm\u00e9 leur confiance dans le potentiel de Spineart \u00e0 fa\u00e7onner l\u2019avenir de la chirurgie du rachis. \u00ab Notre engagement durable envers Spineart refl\u00e8te notre conviction dans la capacit\u00e9 d\u2019innovation de l\u2019entreprise et son fort potentiel de croissance internationale, \u00bb ont d\u00e9clar\u00e9 Bart Diels et Gautier Lefebvre, partners sant\u00e9 chez Gimv.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGS Beteiligungen (EGSB), afin de soutenir sa prochaine phase de croissance et d\u2019expansion internationale.<\/p>\n","protected":false},"author":6,"featured_media":35838,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1163,1142,1182],"class_list":["post-35841","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-rd-fr-2","tag-translational-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale<\/title>\n<meta name=\"description\" content=\"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale\" \/>\n<meta property=\"og:description\" content=\"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T08:02:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-06T08:09:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Spineart l\u00e8ve CHF 25 millions pour acc\u00e9l\u00e9rer son expansion mondiale\",\"datePublished\":\"2025-10-06T08:02:48+00:00\",\"dateModified\":\"2025-10-06T08:09:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\"},\"wordCount\":390,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"R&amp;D\",\"Translational Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\",\"name\":\"Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"datePublished\":\"2025-10-06T08:02:48+00:00\",\"dateModified\":\"2025-10-06T08:09:33+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Spineart d\u00e9veloppe des implants rachidiens de nouvelle g\u00e9n\u00e9ration con\u00e7us pour rendre la chirurgie plus s\u00fbre, plus efficace et plus pr\u00e9cise. | \u00a9 Spineart\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spineart l\u00e8ve CHF 25 millions pour acc\u00e9l\u00e9rer son expansion mondiale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale","description":"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/","og_locale":"fr_FR","og_type":"article","og_title":"Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale","og_description":"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.","og_url":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-06T08:02:48+00:00","article_modified_time":"2025-10-06T08:09:33+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Spineart l\u00e8ve CHF 25 millions pour acc\u00e9l\u00e9rer son expansion mondiale","datePublished":"2025-10-06T08:02:48+00:00","dateModified":"2025-10-06T08:09:33+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/"},"wordCount":390,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","keywords":["Financing","Healthcare","Medical Devices","Medtech","R&amp;D","Translational Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/","url":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/","name":"Spineart l\u00e8ve CHF 25M pour acc\u00e9l\u00e9rer son expansion mondiale","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","datePublished":"2025-10-06T08:02:48+00:00","dateModified":"2025-10-06T08:09:33+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La medtech genevoise Spineart a obtenu un investissement de CHF 25 millions aupr\u00e8s de ses actionnaires historiques Gimv et EGSB.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","width":1180,"height":811,"caption":"Spineart d\u00e9veloppe des implants rachidiens de nouvelle g\u00e9n\u00e9ration con\u00e7us pour rendre la chirurgie plus s\u00fbre, plus efficace et plus pr\u00e9cise. | \u00a9 Spineart"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-25-millions-pour-accelerer-son-expansion-mondiale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Spineart l\u00e8ve CHF 25 millions pour acc\u00e9l\u00e9rer son expansion mondiale"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=35841"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35841\/revisions"}],"predecessor-version":[{"id":35843,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35841\/revisions\/35843"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/35838"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=35841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=35841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=35841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}